Search - tctmd.com

Displaying 201 - 220 of 304

Sort: Relevancy | Date

Presentation

5-Year Outcomes of PCI vs CABG in Patients  With Diabetes Mellitus

Presenter: Akira Marui

February 08, 2015

Presentation

Long-term Outcome of SES and ZES Implantation in Patients With and Without Diabetes

Presenter: K.K.W. Olesen

November 13, 2014

Presentation

Impact of Acute and Chronic Hyperglycemia on In-Hospital Outcomes of Patients With AMI

Presenter: M Fujino

October 20, 2014

Presentation

Impact of Diabetes and Metabolic Syndrome on Acute and Chronic On-Clopidogrel Platelet Reactivity in Patients with Stable CAD Receiving DES

Presenter: Laurent Feldman

October 06, 2014

Presentation

VerifyNow in DIabetes High On-Treatment Platelet Reactivity: Switching from Clopidogrel to Prasugrel

Presenter: J.M. Cubero

October 06, 2014

Presentation

Progression to Overt or Silent CAD in Asymptomatic Patients with Diabetes at High Coronary Risk

Presenter: Michael J. Zellweger

September 25, 2014

Presentation TCT 2014

Thoughtful Insights

Presenter: Steven P. Marso

September 17, 2014

Presentation TCT 2014

Case Presentation

Presenter: Manish A. Parikh

September 17, 2014

Presentation TCT 2014

Case Conclusion: A Diabetic Patient with Double Vessel Coronary Artery Disease How Did I Treat?

Presenter: George D. Dangas, Michael E. Farkouh, Manish A. Parikh

September 16, 2014

Presentation TCT 2014

Chronic Renal Failure: An Emerging Important Risk Modifier in Patients with Multivessel CAD with and without Diabetes?

Presenter: George D. Dangas, Michael E. Farkouh, Usman Baber

September 16, 2014

Presentation TCT 2014

The Case for CABG in Most Patients with Multivessel Disease with and without Diabetes

Presenter: George D. Dangas, Michael E. Farkouh, John D. Puskas

September 16, 2014

Presentation TCT 2014

The Case for PCI in Most Patients with Multivessel Disease with and without Diabetes

Presenter: George D. Dangas, Michael E. Farkouh, Frederick Feit

September 16, 2014

Presentation TCT 2014

The Case for Medical Therapy without Revascularization in Most Patients with and without Diabetes

Presenter: George D. Dangas, Michael E. Farkouh, David J. Maron

September 16, 2014

Presentation TCT 2014

Case Introduction: A Diabetic Patient with Double Vessel Coronary Artery Disease How Should We Treat?

Presenter: George D. Dangas, Michael E. Farkouh, Manish A. Parikh

September 16, 2014

Presentation TCT 2014

Long-term Costs of Directional Atherectomy vs_ Other Treatment Choices for Diabetes Patients with Peripheral Artery Disease: a 24-Month Analysis of Administrative Claims Data

Presenter: Khusrow Niazi

September 16, 2014

Presentation TCT 2014

Impact of Pioglitazone on Cardiovascular Events in Patients with Diabetes Mellitus after Drug-eluting Stent Implantation: Evidence from 3-Year Follow-up Results of the J-DESsERT___

Presenter: Hiroyoshi Yokoi

September 16, 2014

Presentation TCT 2014

Diabetic patients treated with Bioresorbable Vascular Scaffolds show good clinical outcomes at two-year follow-up: A pooled analysis from the ABSORB and SPIRIT trials

Presenter: Javaid Iqbal

September 16, 2014

Presentation TCT 2014

VerifyNow in DIabetes high-on-treatment platelet reactivity: a pharmacodynamic study on switching from clopidogrel to prasugrel (VERDI study)_

Presenter: Jos? Mar?a Cubero G?mez

September 16, 2014

Presentation TCT 2014

Percutaneous Coronary Intervention of Small Vessels in the RESOLUTE Global Clinical Program: The Impact of Diabetes Mellitus

Presenter: Milan Chag

September 16, 2014

Presentation TCT 2014

Consensus and Take-home Messages

Presenter: Taehoon Ahn, Afzalur Rahman, Harvey D. White

September 15, 2014

Advertisement

5-Year Outcomes of PCI vs CABG in Patients  With Diabetes Mellitus

Long-term Outcome of SES and ZES Implantation in Patients With and Without Diabetes

Impact of Acute and Chronic Hyperglycemia on In-Hospital Outcomes of Patients With AMI

Impact of Diabetes and Metabolic Syndrome on Acute and Chronic On-Clopidogrel Platelet Reactivity in Patients with Stable CAD Receiving DES

VerifyNow in DIabetes High On-Treatment Platelet Reactivity: Switching from Clopidogrel to Prasugrel

Progression to Overt or Silent CAD in Asymptomatic Patients with Diabetes at High Coronary Risk

Thoughtful Insights

Case Presentation

Case Conclusion: A Diabetic Patient with Double Vessel Coronary Artery Disease How Did I Treat?

Chronic Renal Failure: An Emerging Important Risk Modifier in Patients with Multivessel CAD with and without Diabetes?

The Case for CABG in Most Patients with Multivessel Disease with and without Diabetes

The Case for PCI in Most Patients with Multivessel Disease with and without Diabetes

The Case for Medical Therapy without Revascularization in Most Patients with and without Diabetes

Case Introduction: A Diabetic Patient with Double Vessel Coronary Artery Disease How Should We Treat?

Long-term Costs of Directional Atherectomy vs_ Other Treatment Choices for Diabetes Patients with Peripheral Artery Disease: a 24-Month Analysis of Administrative Claims Data

Impact of Pioglitazone on Cardiovascular Events in Patients with Diabetes Mellitus after Drug-eluting Stent Implantation: Evidence from 3-Year Follow-up Results of the J-DESsERT___

Diabetic patients treated with Bioresorbable Vascular Scaffolds show good clinical outcomes at two-year follow-up: A pooled analysis from the ABSORB and SPIRIT trials

VerifyNow in DIabetes high-on-treatment platelet reactivity: a pharmacodynamic study on switching from clopidogrel to prasugrel (VERDI study)_

Percutaneous Coronary Intervention of Small Vessels in the RESOLUTE Global Clinical Program: The Impact of Diabetes Mellitus

Consensus and Take-home Messages

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content